Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Eszlinger

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Molecular and Cellular Endocrinology|January 20, 2010
Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patternsMarkus Eszlinger, Ralf Paschke
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Insights from molecular pathways: potential pharmacologic targets of benign thyroid nodulesMarkus Eszlinger, Holger Jaeschke, Ralf Paschke
Best Practice & Research. Clinical Endocrinology & Metabolism|July 23, 2014
Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodulesMarkus Eszlinger, László Hegedüs, Ralf Paschke
European Journal of Endocrinology|July 28, 2022
DIAGNOSIS OF ENDOCRINE DISEASE: Usefulness of genetic testing of fine-needle aspirations for diagnosis of thyroid cancerPaul Stewardson, Markus Eszlinger, Ralf Paschke
The Journal of Clinical Endocrinology and Metabolism|May 20, 2011
Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodulesCarolina Ferraz, Markus Eszlinger, Ralf Paschke
Trends in Endocrinology and Metabolism: TEM|August 2, 2005
The genetics of euthyroid familial goiterYvonne Böttcher, Markus Eszlinger, Anke Tönjes, et al.
European Journal of Endocrinology|November 26, 2002
Thyroglobulin mRNA quantification in the peripheral blood is not a reliable marker for the follow-up of patients with differentiated thyroid cancerMarkus Eszlinger, Susanne Neumann, Lothar Otto, et al.
Clinical Endocrinology|January 30, 2023
Clinical value of molecular markers as diagnostic and prognostic tools to guide treatment of thyroid cancerPablo Valderrabano, Markus Eszlinger, Paul Stewardson, et al.
Thyroid : Official Journal of the American Thyroid Association|March 1, 2020
The Thyrotropin Receptor Mutation Database UpdateAlexandra Stephenson, Lorraine Lau, Markus Eszlinger, et al.
Clinical Endocrinology|September 18, 2010
Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomasHolger Jaeschke, Sandra Mueller, Markus Eszlinger, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Molecular and Cellular Endocrinology|January 20, 2010
Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patternsMarkus Eszlinger, Ralf Paschke
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Insights from molecular pathways: potential pharmacologic targets of benign thyroid nodulesMarkus Eszlinger, Holger Jaeschke, Ralf Paschke
Best Practice & Research. Clinical Endocrinology & Metabolism|July 23, 2014
Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodulesMarkus Eszlinger, László Hegedüs, Ralf Paschke
European Journal of Endocrinology|July 28, 2022
DIAGNOSIS OF ENDOCRINE DISEASE: Usefulness of genetic testing of fine-needle aspirations for diagnosis of thyroid cancerPaul Stewardson, Markus Eszlinger, Ralf Paschke
The Journal of Clinical Endocrinology and Metabolism|May 20, 2011
Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodulesCarolina Ferraz, Markus Eszlinger, Ralf Paschke
Trends in Endocrinology and Metabolism: TEM|August 2, 2005
The genetics of euthyroid familial goiterYvonne Böttcher, Markus Eszlinger, Anke Tönjes, et al.
European Journal of Endocrinology|November 26, 2002
Thyroglobulin mRNA quantification in the peripheral blood is not a reliable marker for the follow-up of patients with differentiated thyroid cancerMarkus Eszlinger, Susanne Neumann, Lothar Otto, et al.
Clinical Endocrinology|January 30, 2023
Clinical value of molecular markers as diagnostic and prognostic tools to guide treatment of thyroid cancerPablo Valderrabano, Markus Eszlinger, Paul Stewardson, et al.
Thyroid : Official Journal of the American Thyroid Association|March 1, 2020
The Thyrotropin Receptor Mutation Database UpdateAlexandra Stephenson, Lorraine Lau, Markus Eszlinger, et al.
Clinical Endocrinology|September 18, 2010
Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomasHolger Jaeschke, Sandra Mueller, Markus Eszlinger, et al.
Pageof 8